AJMC July 13, 2024
In the conclusion to our interview with Jessica K. Paulus, ScD, senior director of real-world research, Ontada, a business of McKesson, she continues the discussion on how the COVID-19 pandemic has affected the lung cancer space. In the previous segment, she explained the pandemic’s potential impact on advanced-stage disease detection trends, and here she further explains how those findings may translate to the real world.
Transcript
How do your findings of more cases of advanced disease and fewer cases of early-stage disease may or may not reflect real-world trends?
There’s been so much interest in the cancer prevention community around some of the stage shifts that we saw in and around and after the COVID-19 pandemic, and this has been...
Today's Sponsors
Today's Sponsor